Send the following on WhatsApp
Continue to Chat雙特異性抗體藥物競爭加劇!基因泰克與艾伯維血癌新藥均獲 FDA 核准 https://geneonline.news/bispecific-antibody-dlbcl-genentech-abbvie/
雙特異性抗體藥物競爭加劇!基因泰克與艾伯維血癌新藥均獲 FDA 核准 https://geneonline.news/bispecific-antibody-dlbcl-genentech-abbvie/